Streetbeat News

Stock Prices

NISN

NiSun International has regained compliance with NASDAQ's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:02 pm

TUSK

Mammoth Energy Services (NASDAQ:TUSK) reported Q2 losses of $(0.09) per share, missing the analyst consensus estimate of $0.10 by 190 percent. This is a 325 percent decrease over earnings of $0.04 per share from the same period last year. The company also reported quarterly sales of $75.43 million, missing the analyst consensus estimate of $86.07 million by 12.36 percent, a 15.89 percent decrease over sales of $89.68 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 11, 2023 | 12:01 pm

MRNS

Over the past 3 months, 5 analysts have published their opinion on Marinus Pharma (NASDAQ:MRNS) stock. The company has an average price target of $21.4, a decrease of 17.69% from the previous average price target of $26.00.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:01 pm

AMZN

Over the past 3 months, 38 analysts have published their opinion on Amazon.com (NASDAQ:AMZN) stock. The company has an average price target of $165.34, an increase of 12.55% from the previous average price target of $146.90. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

BABA

Over the past 3 months, 13 analysts have published their opinion on Alibaba Group Holding (NYSE:BABA) stock. The analysts have an average price target of $135.08 versus the current price of Alibaba at $99.21, implying an upside. The average price target has increased by 2.06% over the past month.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

CPRX

Over the past 3 months, 5 analysts have given their opinion on Catalyst Pharmaceuticals (NASDAQ:CPRX) stock. The average price target is $24.2, implying an upside from the current price of $15.02. The majority of the ratings are bullish, with 4 out of 5 analysts giving a positive outlook.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

CARM

CARISMA Therapeutics (NASDAQ:CARM) has received positive analyst ratings in the last quarter, with 3 bullish and 2 somewhat bullish ratings. The average price target is $10.6, indicating an upside from the current price of $5.93. This average has increased by 6.0% from the previous target of $10.00.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

FUBO

FuboTV (NYSE:FUBO) has received mostly bullish ratings from analysts in the last quarter, with 3 bullish, 1 somewhat bullish, and 2 indifferent ratings. The average 12-month price target for FuboTV has increased by 22.33% from the previous average, now standing at $3.67.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 12:00 pm

AIRS

AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported a 12.2% YoY increase in Q2 revenues to $55.703 million, in line with consensus. However, Q2 adjusted EPS of $0.13 missed the street view of $0.15. The company saw a 13.4% YoY jump in case volume and a significant increase in net income and operating income. The company expects to perform at the higher end of its revenue and Adjusted EBITDA ranges for FY23 and plans to open five new centers.

Portfolio Pulse from Nabaparna Bhattacharya

August 11, 2023 | 11:53 am

MCHI

Nobel Prize-winning economist Paul Krugman has expressed concerns over China's economic situation, stating that the country's economic woes make it more dangerous to global security. He noted that China's GDP growth has now tapered to 4% and the country is trying to invest more than 40% of the GDP, which is not sustainable. He also mentioned that China's government has been resistant to reforms that might make its growth sustainable. The iShares MSCI China ETF (NASDAQ:MCHI), an index tracking Chinese stocks, fell 1.31% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

August 11, 2023 | 11:51 am